Physician profile
Amit Jain
NPI 1144430992
$1,207.20
in general payments reported to CMS, 2019-2025
16 companies · $15.10 in 2025
The $15.10 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $784 · 2020: $46.68 · 2021: $100 · 2022: $97.25 · 2023: $99.62 · 2024: $64.46 · 2025: $15.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $434.99 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $187.56 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $164.19 | 2019-2023 | Keytruda |
| Celgene Corporation | $103.10 | 2023-2024 | Opdualag, Pomalyst |
| Daiichi Sankyo INC. | $43.65 | 2019-2020 | |
| Genentech USA, INC. | $41.74 | 2019 | |
| Janssen Pharmaceuticals, INC | $39.78 | 2019 | |
| Novartis Pharmaceuticals Corporation | $34.14 | 2019-2020 | |
| Incyte Corporation | $32.17 | 2019-2023 | Jakafi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.98 | 2019 | |
| Sirtex Medical INC | $22.47 | 2024 | Sir-Spheres Microspheres |
| Pharmacyclics LLC, An Abbvie Company | $17.60 | 2019 | |
| Alexion Pharmaceuticals, INC. | $17.22 | 2019 | |
| Kite Pharma, INC. | $15.10 | 2025 | Yescarta |
| Pfizer INC. | $12.45 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.